Brief: Tanvex Biopharma Says 9-Month Net Loss At T$1.62 Bln
13/11/2023 08:33
Nov 13 (Reuters) - Tanvex Biopharma Inc 6541.TW :
* SAYS 9-MONTH NET LOSS AT T$1.62 BILLION ($50.11 million)
Source text for Eikon: ID:nMOPbJTlTn
Further company coverage: 6541.TW
($1 = 32.3320 Taiwan dollars)
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Tanvex Biopharma
See all newsBrief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals
Brief: Tanvex Biopharma Says 2023 Net Loss At T$2.14 Bln
Brief: Tanvex Biopharma Says Board Approves Plan To Invest Up To $5 Mln In Taiwan Unit
Brief: Tanvex Biopharma Says 9-Month Net Loss At T$1.62 Bln
Brief: Tanvex Biopharma to issue 25 mln new shares for working capital supplement